Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2024
Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assaysZhe Hu, Alberto Domingo López-Muñoz, Ivan Kosik, et al.Biorxiv : the Preprint Server for Biology|May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue EquivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.Science Immunology|March 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoireIvan Kosik, Jefferson Da Silva Santos, Mathew Angel, et al.Photochemistry and Photobiology|April 7, 2025
Cutaneous photosensitivity of phototheranostic porphyrin-lipid nanoparticlesMichael S Valic, Mark Zheng, Theo Husby, et al.Science Translational Medicine|August 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.Vaccines|June 27, 2025
SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus MacaquesPuthupparampil V Scaria, Christopher G Rowe, Ivan Kosik, et al.Iscience|November 14, 2022
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyondHyung-Joon Kwon, Martina Kosikova, Weichun Tang, et al.Communications Biology|August 12, 2022
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.Biorxiv : the Preprint Server for Biology|April 20, 2022
Broadly neutralizing antibodies target the coronavirus fusion peptideCherrelle Dacon, Courtney Tucker, Linghang Peng, et al.Science (New York, N.Y.)|July 20, 2022
Broadly neutralizing antibodies target the coronavirus fusion peptideCherrelle Dacon, Courtney Tucker, Linghang Peng, et al.Pageof 5